Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gene transfer: Bax to the future for cancer therapy.

Literature DB >> 15016738

Gene transfer: Bax to the future for cancer therapy.

N R Lemoine¹, I A McNeish.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2004 PMID： 15016738 PMCID： PMC1774008 DOI： 10.1136/gut.2003.030312

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

Keyword Cloud
References

× No keyword cloud information.

35 in total

1. Particle assembly incorporating a VP22-BH3 fusion protein, facilitating intracellular delivery, regulated release, and apoptosis.

Authors: N D Brewis; A Phelan; N Normand; E Choolun; P O'Hare
Journal: Mol Ther Date: 2003-02 Impact factor: 11.454

2. Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints.

Authors: Tony Reid; Eva Galanis; James Abbruzzese; Dan Sze; Lawrence M Wein; James Andrews; Britta Randlev; Carla Heise; Margaret Uprichard; Michael Hatfield; Larry Rome; Joseph Rubin; David Kirn
Journal: Cancer Res Date: 2002-11-01 Impact factor: 12.701

3. Enhancement of thymidine kinase-mediated killing of malignant glioma by BimS, a BH3-only cell death activator.

Authors: T Yamaguchi; T Okada; K Takeuchi; T Tonda; M Ohtaki; S Shinoda; T Masuzawa; K Ozawa; T Inaba
Journal: Gene Ther Date: 2003-03 Impact factor: 5.250

4. Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates.

Authors: Julia Lanciotti; Antonius Song; John Doukas; Barbara Sosnowski; Glenn Pierce; Richard Gregory; Samuel Wadsworth; Catherine O'Riordan
Journal: Mol Ther Date: 2003-07 Impact factor: 11.454

5. Development of a formulation that enhances gene expression and efficacy following intraperitoneal administration in rabbits and mice.

Authors: Heidrun Engler; Todd R Machemer; Thomas Schluep; Shu-Fen Wen; Erlinda Quijano; Ken N Wills; Alexis E Harper; Daniel C Maneval; Susan E Conroy
Journal: Mol Ther Date: 2003-04 Impact factor: 11.454

6. p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.

Authors: Daniele Bergamaschi; Milena Gasco; Louise Hiller; Alexandra Sullivan; Nelofer Syed; Giuseppe Trigiante; Isik Yulug; Marco Merlano; Gianmauro Numico; Alberto Comino; Marlene Attard; Olivier Reelfs; Barry Gusterson; Alexandra K Bell; Victoria Heath; Mahvash Tavassoli; Paul J Farrell; Paul Smith; Xin Lu; Tim Crook
Journal: Cancer Cell Date: 2003-04 Impact factor: 31.743

Gene transfer: Bax to the future for cancer therapy.

1. Particle assembly incorporating a VP22-BH3 fusion protein, facilitating intracellular delivery, regulated release, and apoptosis.

2. Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints.

3. Enhancement of thymidine kinase-mediated killing of malignant glioma by BimS, a BH3-only cell death activator.

4. Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates.

5. Development of a formulation that enhances gene expression and efficacy following intraperitoneal administration in rabbits and mice.

6. p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.

Review 7. Why did p53 gene therapy fail in ovarian cancer?

8. Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway.

9. Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer.

10. Regression of upper gastric cancer in mice by FHIT gene delivery.